We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Vera Bradley
VRA
$105M
| $984K | 0.01% |
64,514
-25,581
| -28% | -$374K |
|
652
Forte Biosciences
FBRX
$1.12B
| $970K | 0.01% |
166
+34
| +26% | +$129K |
|
653
Eversource Energy
ES
$28.2B
| $966K | 0.01% |
15,720
-440
| -3% | -$26.9K |
|
|
EPZM
654
DELISTED
Epizyme, Inc
EPZM
| $958K | 0.01% |
90,375
+18,825
| +26% | +$215K |
|
|
IBTX
655
DELISTED
Independent Bank Group, Inc.
IBTX
| $956K | 0.01% |
14,420
-350
| -2% | -$23.9K |
|
656
Innospec
IOSP
$2.09B
| $952K | 0.01% |
12,410
| – | – |
|
657
Curtiss-Wright
CW
$27.7B
| $947K | 0.01% |
6,888
-13,270
| -66% | -$1.74M |
|
658
Haemonetics
HAE
$3.58B
| $940K | 0.01% |
8,201
-47,500
| -85% | -$4.92M |
|
|
WIFI
659
DELISTED
Boingo Wireless, Inc.
WIFI
| $940K | 0.01% |
26,928
-213,568
| -89% | -$6.2M |
|
|
SYRS
660
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $939K | 0.01% |
7,886
+220
| +3% | +$25.5K |
|
|
TBRG
661
DELISTED
TruBridge
TBRG
| $931K | 0.01% |
34,681
+14,310
| +70% | +$419K |
|
|
BMCH
662
DELISTED
BMC Stock Holdings, Inc
BMCH
| $929K | 0.01% |
49,828
-2,700
| -5% | -$58.6K |
|
663
Ecolab
ECL
$75.6B
| $928K | 0.01% |
5,920
-170
| -3% | -$25.2K |
|
664
James River Group Holdings
JRVR
$218M
| $921K | 0.01% |
21,612
-18,119
| -46% | -$741K |
|
665
Park Hotels & Resorts
PK
$2.97B
| $921K | 0.01% |
28,060
-63,310
| -69% | -$2.04M |
|
|
FOLD
666
DELISTED
Amicus Therapeutics
FOLD
| $903K | 0.01% |
74,724
+21,624
| +41% | +$302K |
|
|
DSPG
667
DELISTED
DSP Group Inc
DSPG
| $892K | 0.01% |
74,975
+19,957
| +36% | +$247K |
|
668
Covenant Logistics
CVLG
$1.18B
| $881K | 0.01% |
60,604
+10,434
| +21% | +$158K |
|
|
ALEX
669
DELISTED
Alexander & Baldwin
ALEX
| $879K | 0.01% |
38,731
-56,580
| -59% | -$1.34M |
|
670
EXL Service
EXLS
$4.23B
| $870K | 0.01% |
+65,700
| New | +$813K |
|
|
MRLN
671
DELISTED
Marlin Business Services Corp
MRLN
| $868K | 0.01% |
30,076
-355
| -1% | -$10.4K |
|
672
Nabors Industries
NBR
$1.23B
| $867K | 0.01% |
+2,816
| New | +$870K |
|
673
Columbus McKinnon
CMCO
$465M
| $856K | 0.01% |
21,640
-2,210
| -9% | -$92.3K |
|
|
ACHN
674
DELISTED
Achillion Pharmaceuticals
ACHN
| $850K | 0.01% |
231,113
+17,300
| +8% | +$51.6K |
|
|
ELVT
675
DELISTED
Elevate Credit, Inc.
ELVT
| $847K | 0.01% |
105,053
+91,053
| +650% | +$855K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.